What is Eliquis (Apixaban) and How Does it Work?

Eliquis, also known as apixaban, is a type of medication that is usually prescribed to prevent blood clot formation and stroke in patients that are diagnosed with a certain type of heart rhythm disorder. Since Eliquis works by reducing the risk of forming blood clots, it is quite useful in preventing conditions such as deep vein thrombosis, pulmonary embolism, and stroke. Apixaban falls into a class of medications called direct oral anticoagulants (DOACs), which are commonly used to manage and prevent blood clots and their complications. Eliquis, also known as Apixaban, is a medication prescribed to individuals who are at risk of developing blood clots or have already suffered from a stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), or other related conditions. Eliquis (Apixaban) belongs to a class of drugs known as anticoagulants or blood thinners, which reduce the risk of blood clots and stroke. But, what is Eliquis and how does it work? In this article, we will take a closer look at this medication and everything you need to know.

liquis works by interfering with a specific enzyme called thrombin in the blood. Thrombin is a protein that is responsible for the formation of blood clots in the body, and reducing its activity helps to prevent clot formation. By inhibiting thrombin, Eliquis reduces the risk of blood clot formation, thus reducing the risk of stroke and other complications. Unlike traditional anticoagulant medications, Eliquis does not require regular blood tests or dose adjustments, making it a more convenient option for patients.

Eliquis is usually prescribed to patients diagnosed with atrial fibrillation, a common type of heart rhythm disorder that increases the risk of blood clots forming. The medication is also prescribed in cases of deep vein thrombosis and pulmonary embolism, especially in patients with a history of these conditions. Eliquis can help prevent the formation of new blood clots as well as decrease the size of existing clots in the body.

The dosage of Eliquis may vary from patient to patient, depending on factors such as age, weight, and medical history. It is important to follow the recommended dosage instructions and not to overdose on the medication. Furthermore, it is advised not to abruptly stop taking Eliquis without consulting with a medical professional, as doing so can lead to an increased risk of blood clots and complications.

One of the benefits of using Eliquis is its relatively low risk of causing major bleeding, an adverse effect that is associated with many anticoagulant medications. However, some patients may experience minor side effects such as nausea, dizziness, and headache when taking Eliquis. In rare cases, more serious side effects such as liver damage or allergic reactions can occur. Any concerns or possible side effects should be discussed with a healthcare professional.

Eliquis, or Apixaban, is a prescription medication approved in 2012 by the FDA for the prevention of blood clots and stroke. It works by blocking the action of specific clotting factors in the blood, namely factor Xa, to prevent the formation of blood clots in the arteries and veins. Eliquis is taken by mouth and is absorbed into the bloodstream, reaching its peak concentration within 3-4 hours. The medication is metabolized primarily in the liver and excreted through urine.

The dosage of Eliquis varies according to the individual’s medical condition, weight, age, and other factors. It is usually recommended to take Eliquis twice a day, with or without food, at the same time every day. It is important to follow your doctor’s instructions carefully and not to change the dosage or frequency of Eliquis without consulting them first.

Eliquis has several advantages over other blood thinners such as Warfarin and Heparin. First, Eliquis has a lower risk of bleeding than Warfarin, which requires regular blood tests to monitor coagulation levels. Second, Eliquis has fewer drug interactions than both Warfarin and Heparin, making it a safer option for patients who are taking multiple medications for other conditions. Third, Eliquis has no dietary restrictions, unlike Warfarin, which requires avoiding or limiting certain foods that affect coagulation.

Despite its benefits, Eliquis also has its potential risks and side effects. The most common side effects of Eliquis include bleeding, headache, nausea, minor bruises, and fatigue. However, if you experience severe or prolonged bleeding, seek medical attention immediately. Other serious side effects of Eliquis, although rare, include allergic reactions, liver damage, and spinal or epidural hematoma. It is important to inform your doctor about any unusual symptoms or changes in your health while taking Eliquis.

Conclusion:

Eliquis (apixaban) is a direct oral anticoagulant medication that is prescribed to prevent blood clot formation and its related complications. The medication works by inhibiting the activity of thrombin, a protein that is responsible for the formation of blood clots in the body. Eliquis is commonly prescribed to patients diagnosed with atrial fibrillation, as well as those with a history of deep vein thrombosis and pulmonary embolism. Unlike traditional anticoagulant medications, Eliquis does not require regular blood tests or frequent dose adjustments. Side effects, though rare, can occur and should be discussed with a healthcare professional. Eliquis is a widely prescribed medication for the prevention of blood clots and stroke. Its mechanism of action works by blocking specific clotting factors in the blood to prevent clot formation. Eliquis has several advantages over other blood thinners, including a lower risk of bleeding, fewer drug interactions, and no dietary restrictions. However, Eliquis also has potential risks and side effects, and it is important to follow your doctor’s instructions carefully and inform them about any changes in your health while taking Eliquis. If you or a loved one is prescribed Eliquis, be sure to consult with your doctor to discuss the benefits and risks of this medication.

Ulani Uriah

Umar Nisar was born and raised in the busy city of Abbottabad. As a journalist, Umar Nisar has contributed to many online publications including PAK Today and the Huffing Post. In regards to academics, Umar Nisar earned a degree in business from the Abbottabad UST, Havelian. Umar Nisar follows the money and covers all aspects of emerging tech here at The Hear Up.

Thanks